Please login to the form below

Not currently logged in
Email:
Password:

allergy

This page shows the latest allergy news and features for those working in and with pharma, biotech and healthcare.

FDA grants priority review for AZ, Amgen’s tezepelumab for asthma

FDA grants priority review for AZ, Amgen’s tezepelumab for asthma

Clinically meaningful reductions in AAER were observed in tezepelumab-treated patients regardless of allergy status and fractional exhaled nitric oxide (FeNO) level – biomarkers used by clinicians to inform treatment options. ... Tezepelumab has

Latest news

More from news
Approximately 17 fully matching, plus 230 partially matching documents found.

Latest Intelligence

  • The pandemic preparedness paradox The pandemic preparedness paradox

    In the United States, the National Institute of Allergy and Infectious Diseases alone spends $6bn annually in the labs of some of the best and brightest scientists in the world.

  • The search for effective drug treatments for COVID-19 The search for effective drug treatments for COVID-19

    medicine. to contribute to the medical response in public health emergencies. The EUA was based on then available data from two global clinical trials – the National Institute for Allergy and Infectious

  • Exploring the potential of eosinophils Exploring the potential of eosinophils

    when starting his research career in Southampton, UK before going on to be Professor of Allergy and Respiratory Medicine at Southampton University. ... Working as a clinician at this time meant he was caring for patients with allergies and asthma, in

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    I don’t think the ongoing trials will tell us a lot,” said H Clifford Lane, clinical director at the National Institutes of Allergy and Infectious Diseases (NIAID).

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    This year’s list also highlights three first-in class medicines compared with last year’s list, which contained only one first-in-class medicine, peanut allergy vaccine Palforzia.

More from intelligence
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 13 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....